1. 科研领域：
分子病原生物学暨感染免疫、疫苗构建和诊断制剂研究。负责并完成国家十一五重大科技专项子项目1项， 国家自然科学基金项目4项和部省市项目8项。
2. 主要成果：
(1)《应用单克隆抗体、基因扩增技术对内脏利什曼病诊断及疗效考核研究》，国家科技进步三等奖，获奖时间：1998年，作为第1主研在项目完成人中排列第2。
(2)《军团菌细胞学和分子生物学检测方法的研究及应用》，卫生部科技进步二等奖，获奖时间：1997年，作为第3主研在项目完成人中排列第4。
(3) 国家发明专利（证书号 第3116546号）《一种抗泡球蚴囊壁组织（生发层，角皮层）单克隆抗体的制备和应用》，发明人：王昕、陈建平、刘巧凤，专利号：ZL2012 1 0576667. 7.
(4) Ziyang Jiang, Kai Dong, Zhengsong Huang, Changchun Yuan, Bo Liu, Qiwei Chen, Jianping Chen. Evaluation of the inhibitory effects and the mechanism of terpenoids on Toxoplasma gondii tachyzoites. ActaTropica, 2023, 237: 106741.
(5) Jianhui Zhang, Jiao Li, Kaifeng Hu, Qi Zhou, Xiaoxiao Chen, Jinlei He, Shuangshuang Yin, Yangjian Chi, Xuechun Liao, Yuying Xiao, Hanxiao Qin, Zhiwan Zheng, Jianping Chen. Screening novel vaccine candidates forLeishmania donovaniby combining differential proteomics and immunoinformatics analysis. Frontiers inImmunology, 2022, 13; 902066.
(6) Hanxiao Qin, Jianhui Zhang, Kai Dong, Dali Chen, Dongmei Yuan,Jianping Chen, Metabolic characterization and biomarkers screening for visceral leishmaniasis in golden hamsters. Acta Tropica, 2022, 225: 106222.
(7) Zhiwan Zheng, Jinlei He, Tao Luo, Jianhui Zhang, Qi Zhou, Shuangshuang Yin, Dali Chen, Jie Luo, Jianping Chen, Jiao Li. Mutation Characteristics and Phylogenetic Analysis of Five Leishmania Clinical Isolates. Animals, 2022, 12, 321.
(8) Jianhui Zhang, Jinlei He, Xuechun Liao, Yuying Xiao, Chang Liang, Qi Zhou, Han Chen, Zhiwan Zheng, Hanxiao Qin, Dali Chen, Qiwei Chen, Jiao Li, Jianping Chen. Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis. Immunobiology, 2021, 226：152085.
(9) Zhi-Wan Zheng, Jiao Li, Han Chen, Jin-Lei He, Qi-Wei Chen, Jian-Hui Zhang, Qi Zhou, Da-Li Chen,Jian-Ping Chen. Evaluation ofin vitroantileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A. Parasites Vectors, 2020, 13: 94.
(10) Jianhui Zhang, Jinlei He, Jiao Li, Qi Zhou, Han Chen, Zhiwan Zhen, Qiwei Chen, Dali Chen, Jianping Chen. The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11- Gp63 and Amastin-Gp63 against visceral Leishmaniasis. PLOS ONE, 2020, 15(3): e0230381.
(11) Jinlei He, Fan Huang, Jiao Li, Qiwei Chen, Dali Chen, Jianping Chen. Bioinformatics analysis of four proteins of Leishmania donovani to guide epitopes vaccine design and drug targets selection. Acta Tropica, 2019, 191: 50-59.
(12) Jingle He, Fan Huang, Jianhui Zhang, Han Chen, Qiwei Chen, Junrong Zhang, Jiao Li, Zhiwan Zheng, Dali Chen, Jianping Chen. DNA prime-protein boost vaccine encodingHLA-A2, HLA-A24 and HLA-DR1 restricted epitopes of CaNA2 against visceralleishmaniasis. Immunology, 2019, 156(1): 94-108.
(13) Jinlei He, Fan Huang, Junrong Zhang, Yanxia He, Jiao Li, Qiwei Chen, Dali Chen, Jianping Chen. Recombinant Mip-PilE-FlaA dominant epitopes vaccine candidate against Legionella pneumophila. Immunology Letters, 2017, 186: 33-40.
(14) Dongmei Yuan, Hanxiao, Jianguo Zhang, Lin Liao, Qiwei Chen, Dali Chen, Jianping Chen. Phylogenetic analysis of HSP70 and cyt b gene sequences for Chinese Leishmania isolates and ultrastructural characteristics of Chinese Leishmania sp. Parasitol Res, 2017, 116(2): 693-702.
(15) Zhirong Mou, Jintao Li, Thouraya Boussoffara, Hiroyuki Kishi, Hiroshi Hamana, Peyman Ezzati, Chuanmin Hu, Weijing Yi, Dong Liu, Forough Khadem, Ifeoma Okwor, Ping Jia, Kiyomi Shitaoka, Shufeng Wang, Momar Ndao, Christine Petersen, Jianping Chen, Sima Rafati, Hechmi Louzir, Atsushi Muraguchi, John A. Wilkins, Jude E. UzonnaIdentification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+T cells.Sci Transl Med, 2015 Oct 21; 7(310): 310ra167.
